Merit Medical Systems Common Stock Net 2010-2024 | MMSI

Merit Medical Systems common stock net from 2010 to 2024. Common stock net can be defined as the value of common equity ownership.
  • Merit Medical Systems common stock net for the quarter ending September 30, 2024 was $0.669B, a 3.74% decline year-over-year.
  • Merit Medical Systems common stock net for 2023 was $0.638B, a 5.48% decline from 2022.
  • Merit Medical Systems common stock net for 2022 was $0.675B, a 5.24% increase from 2021.
  • Merit Medical Systems common stock net for 2021 was $0.642B, a 5.82% increase from 2020.
Merit Medical Systems Annual Common Stock Net
(Millions of US $)
2023 $638
2022 $675
2021 $642
2020 $606
2019 $587
2018 $571
2017 $353
2016 $206
2015 $198
2014 $188
2013 $178
2012 $172
2011 $166
2010 $67
2009 $64
Merit Medical Systems Quarterly Common Stock Net
(Millions of US $)
2024-09-30 $669
2024-06-30 $659
2024-03-31 $649
2023-12-31 $638
2023-09-30 $695
2023-06-30 $692
2023-03-31 $681
2022-12-31 $675
2022-09-30 $658
2022-06-30 $652
2022-03-31 $646
2021-12-31 $642
2021-09-30 $634
2021-06-30 $624
2021-03-31 $615
2020-12-31 $606
2020-09-30 $601
2020-06-30 $596
2020-03-31 $590
2019-12-31 $587
2019-09-30 $584
2019-06-30 $579
2019-03-31 $575
2018-12-31 $571
2018-09-30 $568
2018-06-30 $360
2018-03-31 $356
2017-12-31 $353
2017-09-30 $351
2017-06-30 $348
2017-03-31 $344
2016-12-31 $206
2016-09-30 $205
2016-06-30 $200
2016-03-31 $199
2015-12-31 $198
2015-09-30 $196
2015-06-30 $195
2015-03-31 $193
2014-12-31 $188
2014-09-30 $183
2014-06-30 $182
2014-03-31 $179
2013-12-31 $178
2013-09-30 $175
2013-06-30 $174
2013-03-31 $173
2012-12-31 $172
2012-09-30 $171
2012-06-30 $168
2012-03-31 $167
2011-12-31 $166
2011-09-30 $165
2011-06-30 $164
2011-03-31 $71
2010-12-31 $67
2010-09-30 $66
2010-06-30 $65
2010-03-31 $64
2009-12-31 $64
2009-09-30 $62
2009-06-30 $60
2009-03-31 $60
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $5.988B $1.257B
Merit Medical Systems, Inc. provides various peripheral and cardiac intervention products to cure cardiac conditions specific to interventional cardiology and electrophysiology. The company offers products focused in five core product groups: peripheral intervention, cardiac intervention, interventional oncology and spine, cardiovascular and critical care as well as endoscopy. However, the company operates in two revenue segments: Cardiovascular and Endoscopy Devices.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $79.492B 21.23
Becton Dickinson (BDX) United States $66.954B 17.60
Cardinal Health (CAH) United States $29.177B 15.82
West Pharmaceutical Services (WST) United States $23.472B 47.94
Cooper (COO) United States $20.662B 29.41
Labcorp (LH) United States $20.273B 16.81
Align Technology (ALGN) United States $16.462B 31.50
Henry Schein (HSIC) United States $8.478B 16.15
DENTSPLY SIRONA (XRAY) United States $3.620B 9.65
CONMED (CNMD) United States $2.268B 18.93
Patterson (PDCO) United States $1.833B 9.67
STAAR Surgical (STAA) United States $1.458B 53.80
Lifevantage (LFVN) United States $0.171B 22.77
Pro-Dex (PDEX) United States $0.139B 27.71